Anti-Ro and anti-La antibody positive subacute cutaneous lupus erythematosus (SCLE) induced by lansoprazole.
Collette
C
McCourt
Jennifer
J
Somerville
Kevin
K
McKenna
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000009:adverse effects*; D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D000974:Antibodies, Antinuclear / Q000276:immunology*; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006801:Humans; D064747:Lansoprazole; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000276:immunology*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D000974:Antibodies, Antinuclear; D064747:Lansoprazole